SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-14-001164
Filing Date
2014-07-17
Accepted
2014-07-17 12:33:02
Documents
10
Period of Report
2014-07-16

Document Format Files

Seq Description Document Type Size
1 FORM 6-K lorus6k.htm 6-K 11291
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 457479
3 EXHIBIT 99.2 ex99-2.htm EX-99.2 238256
4 EXHIBIT 99.3 ex99-3.htm EX-99.3 336195
5 EXHIBIT 99.4 ex99-4.htm EX-99.4 18695
6 EXHIBIT 99.5 ex99-5.htm EX-99.5 18627
7 GRAPHIC ex99-3_pg06.jpg GRAPHIC 182075
8 GRAPHIC image_001.jpg GRAPHIC 1959
9 GRAPHIC tlogo.jpg GRAPHIC 25381
10 GRAPHIC kpmg_logo.jpg GRAPHIC 2742
  Complete submission text file 0001279569-14-001164.txt   1374695
Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7
Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7 416-798-1200
LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 14979804
SIC: 2836 Biological Products, (No Diagnostic Substances)